AU2002224086B8 - Indole derivatives and use thereof in medicines - Google Patents

Indole derivatives and use thereof in medicines Download PDF

Info

Publication number
AU2002224086B8
AU2002224086B8 AU2002224086A AU2002224086A AU2002224086B8 AU 2002224086 B8 AU2002224086 B8 AU 2002224086B8 AU 2002224086 A AU2002224086 A AU 2002224086A AU 2002224086 A AU2002224086 A AU 2002224086A AU 2002224086 B8 AU2002224086 B8 AU 2002224086B8
Authority
AU
Australia
Prior art keywords
ome
co2et
groups
hydroxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002224086A
Other languages
English (en)
Other versions
AU2002224086B1 (en
Inventor
Takumi Aoki
Koji Kawai
Masayuki Maeda
Satoshi Sakami
Shinya Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of AU2002224086B8 publication Critical patent/AU2002224086B8/en
Publication of AU2002224086B1 publication Critical patent/AU2002224086B1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002224086A 2000-11-22 2001-11-22 Indole derivatives and use thereof in medicines Ceased AU2002224086B8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000356382 2000-11-22
JP2000-356382 2000-11-22
PCT/JP2001/010249 WO2002042309A1 (en) 2000-11-22 2001-11-22 Indole derivatives and use thereof in medicines

Publications (2)

Publication Number Publication Date
AU2002224086B8 true AU2002224086B8 (en) 2002-06-03
AU2002224086B1 AU2002224086B1 (en) 2006-11-16

Family

ID=18828643

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002224086A Ceased AU2002224086B8 (en) 2000-11-22 2001-11-22 Indole derivatives and use thereof in medicines
AU2408602A Pending AU2408602A (en) 2000-11-22 2001-11-22 Indole derivatives and use thereof in medicines

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2408602A Pending AU2408602A (en) 2000-11-22 2001-11-22 Indole derivatives and use thereof in medicines

Country Status (11)

Country Link
US (1) US6770654B2 (OSRAM)
EP (1) EP1342723B1 (OSRAM)
JP (1) JP4292738B2 (OSRAM)
KR (1) KR20030053530A (OSRAM)
CN (1) CN1247591C (OSRAM)
AT (1) ATE402179T1 (OSRAM)
AU (2) AU2002224086B8 (OSRAM)
CA (1) CA2427931A1 (OSRAM)
DE (1) DE60135016D1 (OSRAM)
ES (1) ES2311034T3 (OSRAM)
WO (1) WO2002042309A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
JPWO2004078177A1 (ja) * 2003-03-07 2006-06-08 東レ株式会社 薬物・物質依存治療薬
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
JPWO2008001859A1 (ja) * 2006-06-30 2009-11-26 学校法人北里研究所 オピオイドδ受容体アゴニスト
IT1390848B1 (it) 2008-07-31 2011-10-19 Neuroscienze Pharmaness S C A R L Composti farmaceutici
EP2149370A1 (en) 2008-07-31 2010-02-03 Neuroscienze Pharmaness S.C. A R.L. Diazabicyclic compounds and microemulsions thereof
IT1396951B1 (it) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
HUE069820T2 (hu) 2018-03-08 2025-04-28 Victoria Link Ltd Nalfurafin alkalmazása demielinizációs betegségek kezelésére

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU712012B2 (en) * 1995-09-26 1999-10-28 Toray Industries, Inc. Indole derivatives and medical application thereof

Also Published As

Publication number Publication date
US20040019071A1 (en) 2004-01-29
JP2002220391A (ja) 2002-08-09
WO2002042309A1 (en) 2002-05-30
ATE402179T1 (de) 2008-08-15
EP1342723A4 (en) 2005-02-09
CN1486321A (zh) 2004-03-31
EP1342723B1 (en) 2008-07-23
AU2408602A (en) 2002-06-03
AU2002224086B1 (en) 2006-11-16
JP4292738B2 (ja) 2009-07-08
ES2311034T3 (es) 2009-02-01
DE60135016D1 (de) 2008-09-04
CA2427931A1 (en) 2002-05-30
CN1247591C (zh) 2006-03-29
KR20030053530A (ko) 2003-06-28
EP1342723A1 (en) 2003-09-10
US6770654B2 (en) 2004-08-03

Similar Documents

Publication Publication Date Title
JP3447292B2 (ja) イミダゾピリジン及び胃腸の疾病の治療のためのその使用
US5457208A (en) Kappa opioid receptor antagonists
EP1359146B1 (en) 4-aryl piperidines as opioid receptor binding agents
CN100368414C (zh) 吗啡喃衍生物及其14位取代季铵盐、制备方法和它们的用途
CA2694497C (en) Quaternary opioid carboxamides
US5739145A (en) Antitussive agents
JPWO1993015081A1 (ja) モルヒナン誘導体および医薬用途
US6187782B1 (en) Morphinane derivatives and medicinal use thereof
EA002189B1 (ru) Применение диазепиноиндолов для приготовления лекарственного продукта, ингибирующего фосфодиэстеразу 4
EP1419159A1 (en) 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
EP0960111A1 (en) Morphine derivatives with analgesic activity
JPS6216952B2 (OSRAM)
JPH09508635A (ja) アザ環式誘導体
EP1342723B1 (en) Indole derivatives and use thereof in medicines
JP3253077B2 (ja) ヒドロイソキノリン誘導体
WO1988007858A1 (en) Sulfinyl and sulfonyl substituted 3-benzazepines
US5298622A (en) Spiroindane opiate analogs
JP2985322B2 (ja) イソキノリン誘導体およびその医薬用途
EP0805157B1 (en) Indole derivatives and medicinal use thereof
JPH1087667A (ja) モルフィナンヒドロキサム酸化合物
JPWO1997011948A1 (ja) インドール誘導体およびその医薬用途
GB2121041A (en) N-(2-methoxyethyl)-noroxymorphone
US3880862A (en) 6{62 -Azido-17-cycloalkylmethyl-4,5{60 -epoxymorphinan-3-ols
JPH05247052A (ja) Ｎ−アルキルグルタールイミドの４−（４−ピペリジニル）−チエノ〔３，２−ｃ〕ピリジン誘導体
JPWO1998043978A1 (ja) モルヒナン誘導体及び医薬用途

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
TH Corrigenda

Free format text: IN VOL 20, NO 44, PAGE(S) 4491 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME TORAY INDUSTRIES, INC, APPLICATION NO. 2002224086, UNDER INID 22 CORRECT THE DATE TO READ 22.11.2001

MK14 Patent ceased section 143(a) (annual fees not paid) or expired
TH Corrigenda

Free format text: IN VOL 20, NO 44, PAGE(S) 4491 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME TORAY INDUSTRIES, INC, APPLICATION NO. 2002224086, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 30 MAY 2002